Lee J, Jeon B, Kwon C, Kim H, Kim T, Seo Y
Int J Oncol. 2025; 66(3).
PMID: 39918000
PMC: 11837901.
DOI: 10.3892/ijo.2025.5723.
Benguella-Benmansour M, Boucherit K, Mesli N
Indian J Hematol Blood Transfus. 2025; 41(1):23-30.
PMID: 39917514
PMC: 11794732.
DOI: 10.1007/s12288-024-01827-6.
Chukwuemeka C, Ndubueze C, Kolawole A, Joseph J, Oladipo I, Ofoezie E
Blood Sci. 2024; 7(1):e00215.
PMID: 39726795
PMC: 11671056.
DOI: 10.1097/BS9.0000000000000215.
Yang Y, Peng H, Wang J, Li F
Exp Hematol Oncol. 2024; 13(1):110.
PMID: 39521987
PMC: 11549815.
DOI: 10.1186/s40164-024-00573-9.
Jeffries N, Sadreyev D, Trull E, Chetal K, Yvanovich E, Mansour M
Br J Haematol. 2024; 205(5):2000-2007.
PMID: 39327763
PMC: 11568922.
DOI: 10.1111/bjh.19782.
Exploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management.
Anwar S, Alrumaihi F, Sarwar T, Babiker A, Khan A, Prabhu S
Biomolecules. 2024; 14(6).
PMID: 38927099
PMC: 11201554.
DOI: 10.3390/biom14060697.
Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cells.
Chatain N, Baumeister J, Szymanski de Toledo M, Wong D, Gupta S, Pannen K
Leukemia. 2024; 38(8):1825-1830.
PMID: 38906962
PMC: 11286509.
DOI: 10.1038/s41375-024-02320-9.
Role of reactive oxygen species in myelodysplastic syndromes.
Jing Q, Zhou C, Zhang J, Zhang P, Wu Y, Zhou J
Cell Mol Biol Lett. 2024; 29(1):53.
PMID: 38616283
PMC: 11017617.
DOI: 10.1186/s11658-024-00570-0.
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells.
Kakafika M, Lyta A, Gavriilidis G, Tsiftsoglou S, Miliotou A, Pappas I
Int J Oncol. 2024; 64(4).
PMID: 38426621
PMC: 10919756.
DOI: 10.3892/ijo.2024.5630.
Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?.
Rahme R, Braun T
J Clin Med. 2024; 13(2).
PMID: 38256681
PMC: 10816428.
DOI: 10.3390/jcm13020549.
Recent advances and future directions in etiopathogenesis and mechanisms of reactive oxygen species in cancer treatment.
Verma P, Rishi B, George N, Kushwaha N, Dhandha H, Kaur M
Pathol Oncol Res. 2023; 29:1611415.
PMID: 37920248
PMC: 10618351.
DOI: 10.3389/pore.2023.1611415.
Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia.
Feng L, Zhang P, Gao W, Yu J, Robson S
Front Oncol. 2023; 13:1244280.
PMID: 37746249
PMC: 10513429.
DOI: 10.3389/fonc.2023.1244280.
A Leukemic Target with a Thousand Faces: The Mitochondria.
Maffeo B, Panuzzo C, Moraca A, Cilloni D
Int J Mol Sci. 2023; 24(17).
PMID: 37685874
PMC: 10487524.
DOI: 10.3390/ijms241713069.
Synergistic Combination of Letrozole and Berberine in Ascorbic Acid-Stabilized AuNPs: A Promising Solution for Breast Cancer.
Foudah A, Alam A, Ayman Salkini M, Ross S, Kumar P, Aldawsari M
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37631014
PMC: 10459502.
DOI: 10.3390/ph16081099.
NADPH oxidase mediated oxidative stress signaling in FLT3-ITD acute myeloid leukemia.
Chen Y, Zou Z, Gaman M, Xu L, Li J
Cell Death Discov. 2023; 9(1):208.
PMID: 37391442
PMC: 10313758.
DOI: 10.1038/s41420-023-01528-5.
Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence.
Nizami Z, Aburawi H, Semlali A, Muhammad K, Iratni R
Antioxidants (Basel). 2023; 12(6).
PMID: 37371889
PMC: 10295724.
DOI: 10.3390/antiox12061159.
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.
Tusa I, Menconi A, Tubita A, Rovida E
Cells. 2023; 12(8).
PMID: 37190064
PMC: 10136880.
DOI: 10.3390/cells12081154.
NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions.
Luo H, Urbonaviciute V, Saei A, Lyu H, Gaetani M, Vegvari A
JCI Insight. 2023; 8(7).
PMID: 36853827
PMC: 10132169.
DOI: 10.1172/jci.insight.164875.
Metabolic Health, Mitochondrial Fitness, Physical Activity, and Cancer.
Clemente-Suarez V, Martin-Rodriguez A, Redondo-Florez L, Ruisoto P, Navarro-Jimenez E, Ramos-Campo D
Cancers (Basel). 2023; 15(3).
PMID: 36765772
PMC: 9913323.
DOI: 10.3390/cancers15030814.
The Human Cytomegalovirus β2.7 Long Non-Coding RNA Prevents Induction of Reactive Oxygen Species to Maintain Viral Gene Silencing during Latency.
Perera M, Sinclair J
Int J Mol Sci. 2022; 23(19).
PMID: 36232315
PMC: 9569889.
DOI: 10.3390/ijms231911017.